CONTEXT: Mucosa-associated lymphoid tissue (MALT) lymphomas are most commonly found in the stomach, lungs, orbital soft tissue, salivary glands and thyroid. Involvement of the trachea is extremely rare. CASE REPORT: This report describes a rare case of MALT lymphoma of the trachea in a 71-yearold woman who presented with a one-year history of coughing, dyspnea, hoarseness and weight loss. There was an infiltrative lesion in the mid-trachea. The anatomopathological diagnosis was only made from the fifth endoscopic biopsy attempt. Immunochemotherapy consisting of rituximab, cyclophosphamide, vincristine and prednisone (R-COP) induced complete remission of the symptoms and endoscopic lesion. CONCLUSIONS: MALT lymphoma of the trachea is extremely rare and indolent disease. It has to be considered in the differential diagnosis of airway lesions. It is crucial to obtain an anatomopathological diagnosis from a specialized pathologist. Immunochemotherapy with R-COP induced complete remission of the disease.
INTRODUCTION
Mucosa-associated lymphoid tissue (MALT) lymphomas are most commonly found in the stomach, lungs, orbital soft tissue, salivary glands and thyroid. Cases affecting the conjunctiva, breasts, kidney, skin, liver and prostate, and some involving bone marrow have been reported. 1 Involvement of the trachea is extremely rare, with only fourteen cases found in the literature through a PubMed search with no time limit [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] (Table 1) .
This report describes a rare case of MALT lymphoma of the trachea in a 71-year-old woman who presented with a one-year history of coughing, dyspnea, hoarseness and weight loss. The diagnosis was made only on the fifth biopsy attempt, by means of bronchoscopy. Immunochemotherapy consisting of rituximab, cyclophosphamide, vincristine and prednisone (R-COP)
induced complete remission of symptoms and the endoscopic lesion.
CASE REPORT
A 71-year-old white woman presented with a one-year history of dry coughing, progressive dyspnea, 5 kg weight loss, nocturnal diaphoresis and six months of neck discomfort and hoarseness.
She had a previous medical history of hypertension, which was 
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2 mg and prednisone 100 mg/m 2 for five days every month. Herpes zoster and vincristine neuropathy developed as complications. The herpes was treated using acyclovir and the neuropathy improved after vincristine was withdrawn in the second cycle.
Bronchoscopy after the seventh cycle showed only a scar lesion, and this was confirmed in an anatomopathological sample. Eight cycles were completed with complete remission of symptoms.
DISCUSSION
Primary tumors of the trachea are rare; squamous cell carcinoma and adenoid cystic carcinoma make up 75% of such cases. The clinical picture is similar to that of chronic obstructive pulmonary disease, which often delays the diagnosis. Our patient received treatment for asthma with minimal improvement in symptoms, probably due to steroids. Bronchoscopy and biopsy are essential. Most cases present with a polypoid lesion.
In our case, there was some difficulty in obtaining a sample that would be satisfactory for the anatomopathological analysis.
Only in the fifthbronchoscopy was enough material obtained.
The same problem has been described in another problematic case, 3 and such occurrences may represent a characteristic of the disease. The possibility that treatment can be implemented reinforces the need to obtain an anatomopathological diagnosis.
At presentation, MALT lymphoma is generally localized. The course tends to be indolent and the prognosis is good. 2, 4 In a series of 75 cases of non-gastrointestinal MALT lymphoma, there was complete remission in 79% and partial remission in 21%. The best results were found for thyroid and tear duct tumors, while skin tumors were least responsive. 1 There are no clear guidelines for the treatment of MALT lymphoma, with different therapeutic options depending on the site. 13 When located in the trachea, a diversity of treatments have been shown to be effective: surgical resection, radiotherapy, bronchoscopic therapy, chemotherapy, immunotherapy (rituximab) and immunochemotherapy. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] The treatment can be done in combination or separately. Antibiotic therapy is not indicated, since no antigens like Helicobacter pylori are implicated in the pathophysiology.
CONCLUSION
MALT lymphoma of the trachea is an extremely rare and indolent disease. It has to be considered in the differential diagnosis of airway lesions. It is crucial to obtain an anatomopathological diagnosis from a specialized pathologist.
